Statins (HMG-CoA reductase inhibitors), cholesterol and stroke

被引：1

作者：

Marta-Moreno, J ^{[1
]}

Echeandia, C ^{[1
]}

Oliveros-Cid, A ^{[1
]}

Figuerola, A ^{[1
]}

Mola, S ^{[1
]}

机构：

[1] Hosp Miguel Servet, Serv Neurol, E-50009 Zaragoza, Spain

来源：

REVISTA DE NEUROLOGIA | 1998年 / 27卷 / 159期

关键词：

cerebral ischemia; cholesterol; HMG-CoA reductase; stroke;

D O I：

10.33588/rn.27159.98262

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

The HMG-CoA reductase inhibitors (known as statins) have been shown to reduce morbi-mortality of vascular origin, including transitory ischemic accidents and cerebral infarcts, in a large group of patients. The implications, both clinical and of costs, oblige us to consider analysis of the existing evidence and the answers to a number of questions arising in a field which has not yet received much attention from neurologists.

引用

页码：827 / 830

页数：4

共 50 条

[1] HMG-CoA reductase inhibitors (statins) - A promising approach to stroke prevention
Hess, DC
Demchuk, AM
Brass, LM
Yatsu, FM
NEUROLOGY, 2000, 54 (04) : 790 - 796
[2] THE DISCOVERY AND DEVELOPMENT OF HMG-COA REDUCTASE INHIBITORS
ENDO, A
JOURNAL OF LIPID RESEARCH, 1992, 33 (11) : 1569 - 1582
[3] SYNTHESES OF HMG-COA REDUCTASE INHIBITORS
MIYACHI, N
SUZUKI, M
OHARA, Y
HIYAMA, T
JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN, 1995, 53 (03) : 186 - 196
[4] HMG-CoA reductase inhibitors improve acute ischemic stroke outcome
Moonis, M
Kane, K
Schwiderski, U
Sandage, BW
Fisher, M
STROKE, 2005, 36 (06) : 1298 - 1300
[5] HMG-CoA reductase inhibitors in organ transplantation
Motomura, N
Saito, S
Foegh, ML
JOURNAL OF NEPHROLOGY, 1997, 10 (02) : 68 - 76
[6] HMG-CoA reductase inhibitors in atherosclerosis.
Buckley, BM
INSULIN RESISTANCE, METABOLIC DISEASES AND DIABETIC COMPLICATIONS, 1999, 1177 : 219 - 224
[7] Stroke, statins, and cholesterol - A meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors
Blauw, GJ
Lagaay, AM
Smelt, AHM
Westendorp, RGJ
STROKE, 1997, 28 (05) : 946 - 950
[8] HMG-CoA reductase inhibitors and the risk of stroke. New mechanism(s) independent of cholesterol-lowering
Endres, M
Laufs, U
NERVENARZT, 1998, 69 (08): : 717 - 721
[9] HMG-CoA reductase inhibitors induce apoptosis in pericytes
Boucher, K
Chad, SS
Sharma, P
Hauschka, PV
Solomon, KR
MICROVASCULAR RESEARCH, 2006, 71 (02) : 91 - 102
[10] Is the efficacy of HMG-CoA reductase inhibitors dependent on baseline plasma cholesterol-level?
Cleophas, TJ
van Marum, R
Niemeijer, MG
CLINICAL RESEARCH AND REGULATORY AFFAIRS, 2003, 20 (03) : 341 - 348

← 1 2 3 4 5 →